Health equity is an ambitious goal, but the drive to deliver life-changing innovation to all eligible patients is ...

Building a trusted data foundation The starting line for any successful AI journey is data readiness and quality. Before ...

Nektar Therapeutics has announced top-line results from its trial of rezpegaldesleukin to treat severe to very severe ...

Creative agency Havas Life London has launched an impactful new campaign, ‘The World’s Rarest Disease’, highlighting the ...

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional ...

The 2025 edition of PMLiVE’s T40 list of creative agencies working on advertising, branding, creative and design projects in ...

AstraZeneca and Daiichi Sankyo’s Enhertu, in combination with pertuzumab, has been approved by the US FDA to treat adult ...

Medicus Pharma has announced the completion of patient enrollment for its phase 2 SKNJCT-003 trial, evaluating the safety and ...

The rise of healthcare content creators and the challenge of misinformation If you work in healthcare and want to see if you ...

Researchers at the University of Geneva (UNIGE) have developed in vitro models of the kidneys, liver and heart for the ...

Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and ...

The US FDA has approved the first ever cell-based gene therapy to treat Wiskott-Aldrich syndrome (WAS).